-
Product Insights
Autism Spectrum Disorder (ASD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Autism Spectrum Disorder (ASD) - Drugs In Development, 2023’, provides an overview of the Autism Spectrum Disorder (ASD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Autism Spectrum Disorder (ASD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Metyrosine in Autism Spectrum Disorder (ASD)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Metyrosine in Autism Spectrum Disorder (ASD) Drug Details:L-179 (metyrosine) is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – metyrosine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry metyrosine Drug Details L-179 (metyrosine) is under development for the treatment of autism. The...
-
Sector Analysis
Autism Spectrum Disorder Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 – 2031
The Autism Spectrum Disorder market size was $985.5 million in 2021 and is expected to achieve a CAGR of more than 15% during 2021-2031. Autism spectrum disorder (ASD), also known as autism, is a highly heterogeneous disorder characterized by varying social and communication impairments and pervasive repetitive behaviors, in addition to a wide range of associated non-core symptoms. The ASD market is chronically underserved, with no approved treatments for the core symptoms or most of the associated non-core symptoms.
-
Product Insights
Autism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Autism, also known as a complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communication, and repetitive behaviors. Risk factors include the child’s sex, family history, fragile X syndrome, Tourette syndrome, and epilepsy. Treatment includes SSRIs (selective serotonin reuptake inhibitors), antidepressants, antipsychotics, and sedatives. The Autism drugs in development market research report provides comprehensive information on the therapeutics under development for Autism, complete with analysis by stage of development, drug target, mechanism of action (MoA),...
-
Track & Monitor
Baby Nutrition Insights: Issue 36
"Baby Nutrition Insights: Issue 36", is an analytical report by GlobalData which provides extensive and highly detailed information on the key markets in the Baby Food industry. This quarterly issue provides a review of news and analysis for the infant nutrition industry, covering the April- June 2018 period. Market News includes: in Brazil, Nestlé is struggling due to adverse market conditions; Casa Luker is a new competitor in the Colombian meals category; baby milks manufacturers report positive growth in China;...
-
Track & Monitor
Baby Nutrition Insights: Issue 38
"Baby Nutrition Insights: Issue 38", is an analytical report by GlobalData which provides extensive and highly detailed information on the key markets in the Baby Food industry. This quarterly issue provides a review of news and analysis for the infant nutrition industry, covering the October- December 2018 period. Market News includes: in Canada, Love Child Organics has brought out organic meals comprised of fruit and vegetable purees with quinoa and acerola; in the USA Nestlé is testing a range of...